Effect of Chlorhexidine-Induced Oral Care on Ventilator-Related Some Respiratory System Complications

NCT04505202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2020-10-30

No results posted yet for this study

Summary

Ventilator-associated pneumonia and ventilator-associated treakeabronchitis in respiratory tract infections associated with ventilator are common infections in intensive care unit and cause significant morbidity, mortality and health expenditures in nosocomial infections. Adequate and effective oral care by nurses in intensive care patients, possible complications, intensive care unit stay in the intensive care unit and is very important in terms of mortality.

Conditions

  • Ventilator Associated Pneumonia
  • Tracheobronchitis

Interventions

DRUG

0.12% chlorhexidine gluconate

The patients included in the experimental group (0.12% chlorhexidine gluconate) will receive 3 times daily oral care

DRUG

Placebo

The patients included in the placebo group ( sodium bicarbonate) will receive 3 times daily oral care

Sponsors & Collaborators

  • Karabuk University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-15
Primary Completion
2020-03-03
Completion
2020-09-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04505202 on ClinicalTrials.gov